Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-09-21

FDA Approved: LOTENSIN — Supplemental Application (Validus Pharmaceuticals LLC)

View source ↗

Summary

FDA approved a supplemental application for Lotensin (benazepril hydrochloride) submitted by Validus Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lotensin (benazepril hydrochloride)

Snippet

SUPPL AP for LOTENSIN (BENAZEPRIL HYDROCHLORIDE)